机器学习肝脏组织学评分与非酒精性脂肪性肝炎肝硬化门脉高压评估相关
本研究基于Belapectin 2b期试验中143例代偿期NASH肝硬化且HVPG≥6 mmHg患者,利用机器学习模型从肝活检中提取 septa、结节和纤维化定量特征,构建SNOF、SNOF-V和SNOF-C评分,分别在基线和验证队列中区分CSPH、静脉曲张及HVPG变化,AUC为0.85和0.74、0.86和0.73,SNOF-C的AUROC为0.89。
要点
- SNOF评分≥11.78在基线和验证队列区分CSPH的AUC分别为0.85和0.74。
- SNOF-V评分≥0.57在基线和验证队列区分静脉曲张的AUC分别为0.86和0.73。
- SNOF-C评分区分HVPG变化>20%与未超过20%者的AUROC为0.89。
核心结论
- 机器学习算法准确预测了NASH肝硬化患者的HVPG、CSPH、静脉曲张发生及HVPG变化。
研究设计与样本
- 研究纳入Belapectin 2b期试验中代偿期NASH肝硬化且HVPG≥6 mmHg的患者143例。
- 基线和治疗结束时进行肝活检、HVPG测量和上消化道内镜检查。
- 采用二次谐波产生/双光子激发荧光对septa、结节和纤维化进行自动定量评估(SNOF)。
主要发现
- 共衍生448个组织学变量,其中243个与septa相关、21个与结节相关、184个与纤维化相关。
- SNOF评分≥11.78在基线区分CSPH的AUC为0.85,在验证队列(基线+治疗结束)为0.74。
- SNOF-V评分≥0.57在基线区分静脉曲张的AUC为0.86,在验证队列为0.73。
- SNOF-C评分区分HVPG变化>20%与未超过20%者的AUROC为0.89。
关键数值与推荐
- SNOF评分≥11.78用于区分CSPH,基线AUC=0.85,验证队列AUC=0.74。
- SNOF-V评分≥0.57用于区分静脉曲张,基线AUC=0.86,验证队列AUC=0.73。
- SNOF-C评分区分HVPG变化>20%与未超过20%者,AUROC=0.89。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In cirrhotic nonalcoholic steatohepatitis (NASH) clinical trials, primary efficacy endpoints have been hepatic venous pressure gradient (HVPG), liver histology and clinical liver outcomes. Important histologic features, such as septa thickness, nodules features and fibrosis area have not been included in the histologic assessment and may have important clinical relevance. We assessed these features with a machine learning (ML) model. METHODS: NASH patients with compensated cirrhosis and HVPG ≥6 mm Hg (n = 143) from the Belapectin phase 2b trial were studied. Liver biopsies, HVPG measurements and upper endoscopies were performed at baseline and at end of treatment (EOT). A second harmonic generation/two-photon excitation fluorescence provided an automated quantitative assessment of septa, nodules and fibrosis (SNOF). We created ML scores and tested their association with HVPG, clinically significant HVPG (≥10 mm Hg) and the presence of varices (SNOF-V). RESULTS: We derived 448 histologic variables (243 related to septa, 21 related to nodules and 184 related to fibrosis). The SNOF score (≥11.78) reliably distinguished CSPH at baseline and in the validation cohort (baseline + EOT) [AUC = 0.85 and 0.74, respectively]. The SNOF-V score (≥0.57) distinguished the presence of varices at baseline and in the same validation cohort [AUC = 0.86 and 0.73, respectively]. Finally, the SNOF-C score differentiated those who had >20% change in HVPG against those who did not, with an AUROC of 0.89. CONCLUSION: The ML algorithm accurately predicted HVPG, CSPH, the development of varices and HVPG changes in patients with NASH cirrhosis. The use of ML histology model in NASH cirrhosis trials may improve the assessment of key outcome changes.
引用
- Noureddin M, Goodman Z, Tai D, et al. Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis. Aliment Pharmacol Ther. 2023. PMID: 36647687. doi:10.1111/apt.17363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。